POMDOCTOR LIMITED American Net Income
| POM Stock | 0.24 0.01 4.35% |
As of the 12th of February 2026, POMDOCTOR LIMITED holds the coefficient of variation of (589.01), and Risk Adjusted Performance of (0.13). Concerning fundamental indicators, the technical analysis model allows you to check practical technical drivers of POMDOCTOR LIMITED, as well as the relationship between them. Please check POMDOCTOR LIMITED information ratio and skewness to decide if POMDOCTOR LIMITED is priced more or less accurately, providing market reflects its current price of 0.24 per share. As POMDOCTOR LIMITED appears to be a penny stock we also advise to check out its jensen alpha numbers.
POMDOCTOR LIMITED Total Revenue |
|
| Last Reported | Projected for Next Year | ||
| Net Loss | -43 M | -40.8 M | |
| Net Loss | -43 M | -45.1 M | |
| Net Loss | (1.09) | (1.14) | |
| Net Income Per E B T | 3.45 | 3.21 |
POMDOCTOR | Net Income | Build AI portfolio with POMDOCTOR Stock |
Evaluating POMDOCTOR LIMITED's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into POMDOCTOR LIMITED American's fundamental strength.
Latest POMDOCTOR LIMITED's Net Income Growth Pattern
Below is the plot of the Net Income of POMDOCTOR LIMITED American over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in POMDOCTOR LIMITED financial statement analysis. It represents the amount of money remaining after all of POMDOCTOR LIMITED American operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is POMDOCTOR LIMITED's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in POMDOCTOR LIMITED's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (37.37 M) | 10 Years Trend |
|
Net Income |
| Timeline |
POMDOCTOR Net Income Regression Statistics
| Arithmetic Mean | 413,259,357 | |
| Geometric Mean | 291,288,704 | |
| Coefficient Of Variation | 238.46 | |
| Mean Deviation | 660,731,991 | |
| Median | 53,000,000 | |
| Standard Deviation | 985,469,281 | |
| Sample Variance | 971149.7T | |
| Range | 3.3B | |
| R-Value | (0.15) | |
| Mean Square Error | 1011050.6T | |
| R-Squared | 0.02 | |
| Significance | 0.55 | |
| Slope | (30,221,268) | |
| Total Sum of Squares | 15538395.3T |
POMDOCTOR Net Income History
Other Fundumenentals of POMDOCTOR LIMITED
POMDOCTOR LIMITED Net Income component correlations
POMDOCTOR Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for POMDOCTOR LIMITED is extremely important. It helps to project a fair market value of POMDOCTOR Stock properly, considering its historical fundamentals such as Net Income. Since POMDOCTOR LIMITED's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of POMDOCTOR LIMITED's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of POMDOCTOR LIMITED's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Pharmaceutical Retailers sector continue expanding? Could POMDOCTOR diversify its offerings? Factors like these will boost the valuation of POMDOCTOR LIMITED. Anticipated expansion of POMDOCTOR directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every POMDOCTOR LIMITED data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate POMDOCTOR LIMITED using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating POMDOCTOR LIMITED's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause POMDOCTOR LIMITED's market price to deviate significantly from intrinsic value.
It's important to distinguish between POMDOCTOR LIMITED's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding POMDOCTOR LIMITED should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, POMDOCTOR LIMITED's market price signifies the transaction level at which participants voluntarily complete trades.
POMDOCTOR LIMITED 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to POMDOCTOR LIMITED's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of POMDOCTOR LIMITED.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in POMDOCTOR LIMITED on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding POMDOCTOR LIMITED American or generate 0.0% return on investment in POMDOCTOR LIMITED over 90 days. POMDOCTOR LIMITED is related to or competes with Si Bone, Pacific Biosciences, Airsculpt Technologies, InnovAge Holding, Orthofix Medical, Anavex Life, and Erasca. Pepco Holdings, Inc., through its subsidiaries, engages in the transmission, distribution, and supply of electricity. More
POMDOCTOR LIMITED Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure POMDOCTOR LIMITED's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess POMDOCTOR LIMITED American upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.18) | |||
| Maximum Drawdown | 105.75 | |||
| Value At Risk | (14.72) | |||
| Potential Upside | 10.77 |
POMDOCTOR LIMITED Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for POMDOCTOR LIMITED's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as POMDOCTOR LIMITED's standard deviation. In reality, there are many statistical measures that can use POMDOCTOR LIMITED historical prices to predict the future POMDOCTOR LIMITED's volatility.| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (2.18) | |||
| Total Risk Alpha | (3.95) | |||
| Treynor Ratio | 1.34 |
POMDOCTOR LIMITED February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.13) | |||
| Market Risk Adjusted Performance | 1.35 | |||
| Mean Deviation | 7.23 | |||
| Coefficient Of Variation | (589.01) | |||
| Standard Deviation | 13.71 | |||
| Variance | 188.07 | |||
| Information Ratio | (0.18) | |||
| Jensen Alpha | (2.18) | |||
| Total Risk Alpha | (3.95) | |||
| Treynor Ratio | 1.34 | |||
| Maximum Drawdown | 105.75 | |||
| Value At Risk | (14.72) | |||
| Potential Upside | 10.77 | |||
| Skewness | (4.08) | |||
| Kurtosis | 26.86 |
POMDOCTOR LIMITED Backtested Returns
POMDOCTOR LIMITED maintains Sharpe Ratio (i.e., Efficiency) of -0.13, which implies the firm had a -0.13 % return per unit of volatility over the last 3 months. POMDOCTOR LIMITED exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check POMDOCTOR LIMITED's coefficient of variation of (589.01), and Risk Adjusted Performance of (0.13) to confirm the risk estimate we provide. The company holds a Beta of -1.75, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning POMDOCTOR LIMITED are expected to decrease by larger amounts. On the other hand, during market turmoil, POMDOCTOR LIMITED is expected to outperform it. At this point, POMDOCTOR LIMITED has a negative expected return of -1.86%. Please make sure to check POMDOCTOR LIMITED's jensen alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if POMDOCTOR LIMITED performance from the past will be repeated at future time.
Auto-correlation | 0.87 |
Very good predictability
POMDOCTOR LIMITED American has very good predictability. Overlapping area represents the amount of predictability between POMDOCTOR LIMITED time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of POMDOCTOR LIMITED price movement. The serial correlation of 0.87 indicates that approximately 87.0% of current POMDOCTOR LIMITED price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.87 | |
| Spearman Rank Test | 0.71 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, POMDOCTOR LIMITED American reported net income of (37.37 Million). This is 110.95% lower than that of the sector and significantly lower than that of the Net Income industry. The net income for all United States stocks is 106.54% higher than that of the company.
POMDOCTOR Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses POMDOCTOR LIMITED's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of POMDOCTOR LIMITED could also be used in its relative valuation, which is a method of valuing POMDOCTOR LIMITED by comparing valuation metrics of similar companies.POMDOCTOR LIMITED is currently under evaluation in net income category among its peers.
POMDOCTOR Fundamentals
| Number Of Shares Shorted | 226.09 K | ||||
| Price To Earning | 22.44 X | ||||
| Price To Sales | 1.52 X | ||||
| Revenue | 342.56 M | ||||
| EBITDA | (24.27 M) | ||||
| Net Income | (37.37 M) | ||||
| Cash And Equivalents | 57 M | ||||
| Cash Per Share | 0.10 X | ||||
| Total Debt | 441.1 M | ||||
| Debt To Equity | 1.36 % | ||||
| Current Ratio | 0.52 X | ||||
| Book Value Per Share | 21.28 X | ||||
| Cash Flow From Operations | (16.13 M) | ||||
| Number Of Employees | 156 | ||||
| Beta | 0.66 | ||||
| Market Capitalization | 6.6 B | ||||
| Total Asset | 46.23 M | ||||
| Retained Earnings | (2.26 B) | ||||
| Working Capital | (141.65 M) | ||||
| Current Asset | 1.2 B | ||||
| Current Liabilities | 2.31 B | ||||
| Net Asset | 46.23 M |
About POMDOCTOR LIMITED Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze POMDOCTOR LIMITED American's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of POMDOCTOR LIMITED using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of POMDOCTOR LIMITED American based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Will Pharmaceutical Retailers sector continue expanding? Could POMDOCTOR diversify its offerings? Factors like these will boost the valuation of POMDOCTOR LIMITED. Anticipated expansion of POMDOCTOR directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every POMDOCTOR LIMITED data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate POMDOCTOR LIMITED using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating POMDOCTOR LIMITED's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause POMDOCTOR LIMITED's market price to deviate significantly from intrinsic value.
It's important to distinguish between POMDOCTOR LIMITED's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding POMDOCTOR LIMITED should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, POMDOCTOR LIMITED's market price signifies the transaction level at which participants voluntarily complete trades.